Schedule 13D ownership disclosure
Evofem Biosciences Operations, Inc.
Security class unavailable · CUSIP: 30048L104
Event date: 2019-06-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 11,812,910
- Percent of class
- 25.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-19-000317
- Form type
- SC 13D
- Filer
- Evofem Biosciences, Inc.
- CIK
- CIK 1618835
- Filed
- Jun 12, 2019
- Reporting period
- Jun 10, 2019
- Description
- Schedule 13D beneficial ownership